Indo Count Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 2:51 pm

Quick Insight

Indo Count Industries Ltd, operating in the cotton blended textiles sector, currently trades at ₹295 with a market capitalization of ₹5,858 crore, reflecting a price-to-earnings (P/E) ratio of 23.8. The company showcases a respectable return on equity (ROE) of 11.3% and a return on capital employed (ROCE) of 13.5%, indicating efficient capital utilization. With an operating profit margin (OPM) of 8% and net profits amounting to ₹246 crore, Indo Count appears financially stable, supported by reserves of ₹2,238 crore against borrowings of ₹1,449 crore, yielding an interest coverage ratio (ICR) of 8.63x. However, the relatively high price-to-book value (P/BV) ratio of 3.35x suggests that the stock may be overvalued compared to its tangible assets. Investors should weigh these factors carefully, particularly the prolonged cash conversion cycle

Competitors of Indo Count Industries Ltd

All Competitor Stocks of Indo Count Industries Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:52 am

Below is a detailed analysis of the quarterly data for Indo Count Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 1,023.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,152.00 Cr. (Dec 2024) to 1,023.00 Cr., marking a decrease of 129.00 Cr..
• For Expenses, as of Mar 2025, the value is 941.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,002.00 Cr. (Dec 2024) to 941.00 Cr., marking a decrease of 61.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 82.00 Cr.. The value appears to be declining and may need further review. It has decreased from 149.00 Cr. (Dec 2024) to 82.00 Cr., marking a decrease of 67.00 Cr..
• For OPM %, as of Mar 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 13.00% (Dec 2024) to 8.00%, marking a decrease of 5.00%.
• For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Dec 2024) to 6.00 Cr., marking a decrease of 10.00 Cr..
• For Interest, as of Mar 2025, the value is 36.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 36.00 Cr..
• For Depreciation, as of Mar 2025, the value is 36.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.00 Cr. (Dec 2024) to 36.00 Cr., marking an increase of 6.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Dec 2024) to 16.00 Cr., marking a decrease of 84.00 Cr..
• For Tax %, as of Mar 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Dec 2024) to 28.00%, marking an increase of 4.00%.
• For Net Profit, as of Mar 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Dec 2024) to 11.00 Cr., marking a decrease of 64.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.57. The value appears to be declining and may need further review. It has decreased from 3.81 (Dec 2024) to 0.57, marking a decrease of 3.24.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:38 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:57 am

Below is a detailed analysis of the balance sheet data for Indo Count Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 40.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 40.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,238.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,049.00 Cr. (Mar 2024) to 2,238.00 Cr., marking an increase of 189.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,449.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 956.00 Cr. (Mar 2024) to 1,449.00 Cr., marking an increase of 493.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 533.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 524.00 Cr. (Mar 2024) to 533.00 Cr., marking an increase of 9.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 4,260.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,569.00 Cr. (Mar 2024) to 4,260.00 Cr., marking an increase of 691.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,912.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,355.00 Cr. (Mar 2024) to 1,912.00 Cr., marking an increase of 557.00 Cr..
• For CWIP, as of Mar 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2024) to 28.00 Cr., marking a decrease of 7.00 Cr..
• For Investments, as of Mar 2025, the value is 135.00 Cr.. The value appears strong and on an upward trend. It has increased from 133.00 Cr. (Mar 2024) to 135.00 Cr., marking an increase of 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,185.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,046.00 Cr. (Mar 2024) to 2,185.00 Cr., marking an increase of 139.00 Cr..
• For Total Assets, as of Mar 2025, the value is 4,260.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,569.00 Cr. (Mar 2024) to 4,260.00 Cr., marking an increase of 691.00 Cr..

Notably, the Reserves (2,238.00 Cr.) exceed the Borrowings (1,449.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Indo Count Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 17.06. This value is within the healthy range. It has increased from 13.97 (Mar 23) to 17.06, marking an increase of 3.09.
• For Diluted EPS (Rs.), as of Mar 24, the value is 17.06. This value is within the healthy range. It has increased from 13.97 (Mar 23) to 17.06, marking an increase of 3.09.
• For Cash EPS (Rs.), as of Mar 24, the value is 21.23. This value is within the healthy range. It has increased from 17.24 (Mar 23) to 21.23, marking an increase of 3.99.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 105.48. It has increased from 90.52 (Mar 23) to 105.48, marking an increase of 14.96.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 105.48. It has increased from 90.52 (Mar 23) to 105.48, marking an increase of 14.96.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 179.60. It has increased from 152.06 (Mar 23) to 179.60, marking an increase of 27.54.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 30.43. This value is within the healthy range. It has increased from 24.52 (Mar 23) to 30.43, marking an increase of 5.91.
• For PBIT / Share (Rs.), as of Mar 24, the value is 26.26. This value is within the healthy range. It has increased from 21.25 (Mar 23) to 26.26, marking an increase of 5.01.
• For PBT / Share (Rs.), as of Mar 24, the value is 22.74. This value is within the healthy range. It has increased from 18.11 (Mar 23) to 22.74, marking an increase of 4.63.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 17.06. This value is within the healthy range. It has increased from 13.97 (Mar 23) to 17.06, marking an increase of 3.09.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 17.06. This value is within the healthy range. It has increased from 13.97 (Mar 23) to 17.06, marking an increase of 3.09.
• For PBDIT Margin (%), as of Mar 24, the value is 16.94. This value is within the healthy range. It has increased from 16.12 (Mar 23) to 16.94, marking an increase of 0.82.
• For PBIT Margin (%), as of Mar 24, the value is 14.62. This value is within the healthy range. It has increased from 13.97 (Mar 23) to 14.62, marking an increase of 0.65.
• For PBT Margin (%), as of Mar 24, the value is 12.65. This value is within the healthy range. It has increased from 11.90 (Mar 23) to 12.65, marking an increase of 0.75.
• For Net Profit Margin (%), as of Mar 24, the value is 9.50. This value is within the healthy range. It has increased from 9.19 (Mar 23) to 9.50, marking an increase of 0.31.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.50. This value is within the healthy range. It has increased from 9.19 (Mar 23) to 9.50, marking an increase of 0.31.
• For Return on Networth / Equity (%), as of Mar 24, the value is 16.17. This value is within the healthy range. It has increased from 15.43 (Mar 23) to 16.17, marking an increase of 0.74.
• For Return on Capital Employeed (%), as of Mar 24, the value is 21.77. This value is within the healthy range. It has increased from 20.02 (Mar 23) to 21.77, marking an increase of 1.75.
• For Return On Assets (%), as of Mar 24, the value is 9.46. This value is within the healthy range. It has increased from 9.04 (Mar 23) to 9.46, marking an increase of 0.42.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.11 (Mar 23) to 0.06, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.43. This value is within the healthy range. It has decreased from 0.46 (Mar 23) to 0.43, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.07. It has increased from 0.95 (Mar 23) to 1.07, marking an increase of 0.12.
• For Current Ratio (X), as of Mar 24, the value is 1.81. This value is within the healthy range. It has increased from 1.79 (Mar 23) to 1.81, marking an increase of 0.02.
• For Quick Ratio (X), as of Mar 24, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 23) to 0.84, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.63. This value is below the healthy minimum of 4. It has increased from 1.40 (Mar 23) to 1.63, marking an increase of 0.23.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 11.72. This value is below the healthy minimum of 20. It has decreased from 14.26 (Mar 23) to 11.72, marking a decrease of 2.54.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 9.41. This value is below the healthy minimum of 20. It has decreased from 11.56 (Mar 23) to 9.41, marking a decrease of 2.15.
• For Earning Retention Ratio (%), as of Mar 24, the value is 88.28. This value exceeds the healthy maximum of 70. It has increased from 85.74 (Mar 23) to 88.28, marking an increase of 2.54.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 90.59. This value exceeds the healthy maximum of 70. It has increased from 88.44 (Mar 23) to 90.59, marking an increase of 2.15.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 8.63. This value is within the healthy range. It has increased from 7.79 (Mar 23) to 8.63, marking an increase of 0.84.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 5.84. This value is within the healthy range. It has increased from 5.44 (Mar 23) to 5.84, marking an increase of 0.40.
• For Enterprise Value (Cr.), as of Mar 24, the value is 7,804.20. It has increased from 2,949.12 (Mar 23) to 7,804.20, marking an increase of 4,855.08.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.19. This value is within the healthy range. It has increased from 0.97 (Mar 23) to 2.19, marking an increase of 1.22.
• For EV / EBITDA (X), as of Mar 24, the value is 12.95. This value is within the healthy range. It has increased from 6.07 (Mar 23) to 12.95, marking an increase of 6.88.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.97. This value is within the healthy range. It has increased from 0.73 (Mar 23) to 1.97, marking an increase of 1.24.
• For Retention Ratios (%), as of Mar 24, the value is 88.27. This value exceeds the healthy maximum of 70. It has increased from 85.73 (Mar 23) to 88.27, marking an increase of 2.54.
• For Price / BV (X), as of Mar 24, the value is 3.35. This value exceeds the healthy maximum of 3. It has increased from 1.24 (Mar 23) to 3.35, marking an increase of 2.11.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.97. This value is within the healthy range. It has increased from 0.73 (Mar 23) to 1.97, marking an increase of 1.24.
• For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 23) to 0.04, marking a decrease of 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness